Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Assessing pain in the postoperative period: Analgesia Nociception IndexTMvs pupillometry.

Charier D, Vogler MC, Zantour D, Pichot V, Martins-Baltar A, Courbon M, Roche F, Vassal F, Molliex S.

Br J Anaesth. 2019 Jan 26. pii: S0007-0912(18)31383-7. doi: 10.1016/j.bja.2018.09.031. [Epub ahead of print]

PMID:
30915996
2.

Genetically encoded biotin analogs: Incorporation and application in bacterial and mammalian cells.

Hohl A, Mideksa YG, Karan R, Akal A, Vogler M, Groll M, Rueping M, Lang K, Feige MJ, Eppinger J.

Chembiochem. 2019 Mar 21. doi: 10.1002/cbic.201900015. [Epub ahead of print]

PMID:
30900320
3.

A polyextremophilic alcohol dehydrogenase from the Atlantis II Deep Red Sea brine pool.

Akal AL, Karan R, Hohl A, Alam I, Vogler M, Grötzinger SW, Eppinger J, Rueping M.

FEBS Open Bio. 2018 Dec 18;9(2):194-205. doi: 10.1002/2211-5463.12557. eCollection 2019 Feb.

4.

Hypoxia suppresses myofibroblast differentiation by changing RhoA activity.

Leinhos L, Peters J, Krull S, Helbig L, Vogler M, Levay M, van Belle GJ, Ridley AJ, Lutz S, Katschinski DM, Zieseniss A.

J Cell Sci. 2019 Feb 18;132(5). pii: jcs223230. doi: 10.1242/jcs.223230.

PMID:
30659117
5.

Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in hematologic malignancies.

Al-Zebeeby A, Vogler M, Milani M, Richards C, Alotibi A, Greaves G, Dyer MJS, Cohen GM, Varadarajan S.

Haematologica. 2019 May;104(5):1016-1025. doi: 10.3324/haematol.2018.204701. Epub 2018 Nov 22.

6.

Identification of Smac mimetics as novel substrates for p-glycoprotein.

Hugle M, Czaplinski S, Habermann K, Vogler M, Fulda S.

Cancer Lett. 2019 Jan;440-441:126-134. doi: 10.1016/j.canlet.2018.10.001. Epub 2018 Oct 9.

PMID:
30312727
7.

Regional variations in UK colorectal cancer screening and mortality.

George AT, Aggarwal S, Dharmavaram S, Menon A, Dube M, Vogler M, Foden P, Field A.

Lancet. 2018 Jul 28;392(10144):277-278. doi: 10.1016/S0140-6736(18)31208-X. No abstract available.

PMID:
30064645
8.

Enantioselective Nazarov Cyclizations Catalyzed by an Axial Chiral C6 F5 -Substituted Boron Lewis Acid.

Süsse L, Vogler M, Mewald M, Kemper B, Irran E, Oestreich M.

Angew Chem Int Ed Engl. 2018 Aug 27;57(35):11441-11444. doi: 10.1002/anie.201806011. Epub 2018 Jul 26.

PMID:
29978948
9.

Substituent effects in pyridyl-functionalized pyrylium salts, pyridines and λ32-phosphinines: a fundamental and systematic study.

Loibl A, Oschmann W, Vogler M, Pidko EA, Weber M, Wiecko J, Müller C.

Dalton Trans. 2018 Jul 17;47(28):9355-9366. doi: 10.1039/c8dt01441h.

PMID:
29951650
10.

Selective BH3-mimetics targeting BCL-2, BCL-XL or MCL-1 induce severe mitochondrial perturbations.

Henz K, Al-Zebeeby A, Basoglu M, Fulda S, Cohen GM, Varadarajan S, Vogler M.

Biol Chem. 2019 Jan 28;400(2):181-185. doi: 10.1515/hsz-2018-0233.

PMID:
29924730
11.

BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis.

Heinicke U, Haydn T, Kehr S, Vogler M, Fulda S.

Oncogene. 2018 Sep;37(39):5325-5339. doi: 10.1038/s41388-018-0212-5. Epub 2018 Jun 1.

PMID:
29858601
12.

S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth.

Casara P, Davidson J, Claperon A, Le Toumelin-Braizat G, Vogler M, Bruno A, Chanrion M, Lysiak-Auvity G, Le Diguarher T, Starck JB, Chen I, Whitehead N, Graham C, Matassova N, Dokurno P, Pedder C, Wang Y, Qiu S, Girard AM, Schneider E, Gravé F, Studeny A, Guasconi G, Rocchetti F, Maïga S, Henlin JM, Colland F, Kraus-Berthier L, Le Gouill S, Dyer MJS, Hubbard R, Wood M, Amiot M, Cohen GM, Hickman JA, Morris E, Murray J, Geneste O.

Oncotarget. 2018 Apr 13;9(28):20075-20088. doi: 10.18632/oncotarget.24744. eCollection 2018 Apr 13.

13.

Co-targeting of BET proteins and HDACs as a novel approach to trigger apoptosis in rhabdomyosarcoma cells.

Enßle JC, Boedicker C, Wanior M, Vogler M, Knapp S, Fulda S.

Cancer Lett. 2018 Aug 1;428:160-172. doi: 10.1016/j.canlet.2018.04.032. Epub 2018 Apr 27.

PMID:
29709701
14.

Responses to the Selective Bruton's Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines.

Kozaki R, Vogler M, Walter HS, Jayne S, Dinsdale D, Siebert R, Dyer MJS, Yoshizawa T.

Cancers (Basel). 2018 Apr 23;10(4). pii: E127. doi: 10.3390/cancers10040127.

15.

NRAS-Mutated Rhabdomyosarcoma Cells Are Vulnerable to Mitochondrial Apoptosis Induced by Coinhibition of MEK and PI3Kα.

Dolgikh N, Hugle M, Vogler M, Fulda S.

Cancer Res. 2018 Apr 15;78(8):2000-2013. doi: 10.1158/0008-5472.CAN-17-1737. Epub 2018 Feb 6.

16.

BCL-xL-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosis.

Faqar-Uz-Zaman SF, Heinicke U, Meister MT, Vogler M, Fulda S.

Cancer Lett. 2018 Jan 1;412:131-142. doi: 10.1016/j.canlet.2017.09.025. Epub 2017 Sep 23.

PMID:
28947136
17.

Inpatient rehabilitation for adult patients with Marfan syndrome: an observational pilot study.

Benninghoven D, Hamann D, von Kodolitsch Y, Rybczynski M, Lechinger J, Schroeder F, Vogler M, Hoberg E.

Orphanet J Rare Dis. 2017 Jul 12;12(1):127. doi: 10.1186/s13023-017-0679-0.

18.

Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatment.

Vogler M, Walter HS, Dyer MJS.

Br J Haematol. 2017 Aug;178(3):364-379. doi: 10.1111/bjh.14684. Epub 2017 Apr 27. Review.

PMID:
28449207
19.

Faecal occult blood testing screening for colorectal cancer and 'missed' interval cancers: are we ignoring the elephant in the room? Results of a multicentre study.

George AT, Aggarwal S, Dharmavaram S, Menon A, Dube M, Vogler M, Field A.

Colorectal Dis. 2017 May;19(5):O108-O114. doi: 10.1111/codi.13585.

PMID:
27992095
20.

The role of the multidisciplinary health care team in the management of patients with Marfan syndrome.

von Kodolitsch Y, Rybczynski M, Vogler M, Mir TS, Schüler H, Kutsche K, Rosenberger G, Detter C, Bernhardt AM, Larena-Avellaneda A, Kölbel T, Debus ES, Schroeder M, Linke SJ, Fuisting B, Napp B, Kammal AL, Püschel K, Bannas P, Hoffmann BA, Gessler N, Vahle-Hinz E, Kahl-Nieke B, Thomalla G, Weiler-Normann C, Ohm G, Neumann S, Benninghoven D, Blankenberg S, Pyeritz RE.

J Multidiscip Healthc. 2016 Nov 3;9:587-614. eCollection 2016. Review.

21.

Oxygen-dependent regulation of aquaporin-3 expression.

Hoogewijs D, Vogler M, Zwenger E, Krull S, Zieseniss A.

Hypoxia (Auckl). 2016 Apr 21;4:91-97. eCollection 2016.

22.

Circulating Endothelial Cells Expressing the Angiogenic Transcription Factor Krüppel-Like Factor 4 are Decreased in Patients with Coronary Artery Disease.

Czepluch FS, Vogler M, Kuschicke H, Meier J, Gogiraju R, Katschinski DM, Riggert J, Hasenfuss G, Schäfer K.

Microcirculation. 2015 Nov;22(8):700-10. doi: 10.1111/micc.12226.

PMID:
26214161
23.

Erratum to: Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 cases.

Leone M, Bechis C, Baumstarck K, Ouattara A, Collange O, Augustin P, Annane D, Arbelot C, Asehnoune K, Baldési O, Bourcier S, Delapierre L, Demory D, Hengy B, Ichai C, Kipnis E, Brasdefer E, Lasocki S, Legrand M, Mimoz O, Rimmelé T, Aliane J, Bertrand PM, Bruder N, Klasen F, Friou E, Lévy B, Martinez O, Peytel E, Piton A, Richter E, Kamel T, Vogler MC, Wallet F, Boufi M, Allaouchiche B, Constantin JM, Martin C, Jaber S, Lefrant JY.

Intensive Care Med. 2015 May;41(5):966-8. doi: 10.1007/s00134-015-3738-9. No abstract available.

PMID:
25761541
24.

Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 cases.

Leone M, Bechis C, Baumstarck K, Ouattara A, Collange O, Augustin P, Annane D, Arbelot C, Asehnoune K, Baldési O, Bourcier S, Delapierre L, Demory D, Hengy B, Ichai C, Kipnis E, Brasdefer E, Lasocki S, Legrand M, Mimoz O, Rimmelé T, Aliane J, Bertrand PM, Bruder N, Klasen F, Friou E, Lévy B, Martinez O, Peytel E, Piton A, Richter E, Toufik K, Vogler MC, Wallet F, Boufi M, Allaouchiche B, Constantin JM, Martin C, Jaber S, Lefrant JY.

Intensive Care Med. 2015 Apr;41(4):667-76. doi: 10.1007/s00134-015-3690-8. Epub 2015 Mar 3. Erratum in: Intensive Care Med. 2015 May;41(5):966-8.

25.

Pre- and post-conditional inhibition of prolyl-4-hydroxylase domain enzymes protects the heart from an ischemic insult.

Vogler M, Zieseniss A, Hesse AR, Levent E, Tiburcy M, Heinze E, Burzlaff N, Schley G, Eckardt KU, Willam C, Katschinski DM.

Pflugers Arch. 2015 Oct;467(10):2141-9. doi: 10.1007/s00424-014-1667-z. Epub 2015 Jan 13.

PMID:
25578858
26.

[Genetics and prevention of genetic aortic syndromes (GAS) and of the Marfan syndrome].

von Kodolitsch Y, Blankart CR, Vogler M, Kallenbach K, Robinson PN.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Feb;58(2):146-53. doi: 10.1007/s00103-014-2093-2. German.

PMID:
25446311
27.

Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227.

Vogler MA, Smeaton LM, Wright RL, Cardoso SW, Sanchez J, Infante R, Moran LE, Godfrey C, Demeter LM, Johnson VA.

J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):542-50. doi: 10.1097/QAI.0000000000000072.

28.

Interval bowel cancers may not be detected on faecal occult blood testing.

George AT, Aggarwal S, Fields A, Vogler M, Menon A, Dube M.

BMJ. 2014 Apr 3;348:g2390. doi: 10.1136/bmj.g2390. No abstract available.

PMID:
24699121
29.

[One case of perioperative rhabdomyolysis: don't forget the pathophysiology!].

Vogler MC, De Pasquale V, Molliex S.

Ann Fr Anesth Reanim. 2014 Jan;33(1):51-2. doi: 10.1016/j.annfar.2013.11.019. Epub 2013 Dec 27. French. No abstract available.

PMID:
24373675
30.

Targeting BCL2-Proteins for the Treatment of Solid Tumours.

Vogler M.

Adv Med. 2014;2014:943648. doi: 10.1155/2014/943648. Epub 2014 Aug 27. Review.

31.

Hypoxia modulates fibroblastic architecture, adhesion and migration: a role for HIF-1α in cofilin regulation and cytoplasmic actin distribution.

Vogler M, Vogel S, Krull S, Farhat K, Leisering P, Lutz S, Wuertz CM, Katschinski DM, Zieseniss A.

PLoS One. 2013 Jul 18;8(7):e69128. doi: 10.1371/journal.pone.0069128. Print 2013.

32.

Evaluation and critical assessment of putative MCL-1 inhibitors.

Varadarajan S, Vogler M, Butterworth M, Dinsdale D, Walensky LD, Cohen GM.

Cell Death Differ. 2013 Nov;20(11):1475-84. doi: 10.1038/cdd.2013.79. Epub 2013 Jul 5.

33.

ABT-199 selectively inhibits BCL2 but not BCL2L1 and efficiently induces apoptosis of chronic lymphocytic leukaemic cells but not platelets.

Vogler M, Dinsdale D, Dyer MJ, Cohen GM.

Br J Haematol. 2013 Oct;163(1):139-42. doi: 10.1111/bjh.12457. Epub 2013 Jul 4. No abstract available.

PMID:
23826785
34.

Precision medicines for B-cell leukaemias and lymphomas; progress and potential pitfalls.

Dyer MJ, Vogler M, Samuel J, Jayne S, Wagner S, Pritchard C, Macip S.

Br J Haematol. 2013 Mar;160(6):725-33. doi: 10.1111/bjh.12219. Epub 2013 Jan 24.

PMID:
23346939
35.

Single digit nanofabrication by step-and-repeat nanoimprint lithography.

Peroz C, Dhuey S, Cornet M, Vogler M, Olynick D, Cabrini S.

Nanotechnology. 2012 Jan 13;23(1):015305. doi: 10.1088/0957-4484/23/1/015305. Epub 2011 Dec 8.

PMID:
22155980
36.

BCL2A1: the underdog in the BCL2 family.

Vogler M.

Cell Death Differ. 2012 Jan;19(1):67-74. doi: 10.1038/cdd.2011.158. Epub 2011 Nov 11. Review.

37.

BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation.

Vogler M, Hamali HA, Sun XM, Bampton ET, Dinsdale D, Snowden RT, Dyer MJ, Goodall AH, Cohen GM.

Blood. 2011 Jun 30;117(26):7145-54. doi: 10.1182/blood-2011-03-344812. Epub 2011 May 11.

38.

The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein.

Vogler M, Dickens D, Dyer MJ, Owen A, Pirmohamed M, Cohen GM.

Biochem Biophys Res Commun. 2011 May 6;408(2):344-9. doi: 10.1016/j.bbrc.2011.04.043. Epub 2011 Apr 13.

PMID:
21514278
39.

Complex decisions in managing HIV infection during pregnancy.

Vogler MA, Singh H, Wright R.

Curr HIV/AIDS Rep. 2011 Jun;8(2):122-31. doi: 10.1007/s11904-011-0077-5. Review.

PMID:
21455746
40.

Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188.

Vogler MA, Patterson K, Kamemoto L, Park JG, Watts H, Aweeka F, Klingman KL, Cohn SE.

J Acquir Immune Defic Syndr. 2010 Dec;55(4):473-82. doi: 10.1097/QAI.0b013e3181eb5ff5.

41.

[Analysis of costs and profits of ambulatory care of Marfan patients after initiation of a novel German legal directive (116 b SGB V)].

Manow ML, Paulsen N, Rybczynski M, Mir T, Bernhardt AM, Treede H, Ohm G, Fuisting B, Rehder U, Meier F, Vogler M, Meinertz T, Overlack K, von Kodolitsch Y.

Med Klin (Munich). 2010 Aug;105(8):529-37. doi: 10.1007/s00063-010-1090-y. Epub 2010 Sep 8. German.

PMID:
20824410
42.

Model anodes and anode models for understanding the mechanism of hydrogen oxidation in solid oxide fuel cells.

Bessler WG, Vogler M, Störmer H, Gerthsen D, Utz A, Weber A, Ivers-Tiffée E.

Phys Chem Chem Phys. 2010 Nov 14;12(42):13888-903. doi: 10.1039/c0cp00541j. Epub 2010 Aug 31.

PMID:
20820576
43.

Diminished sensitivity of chronic lymphocytic leukemia cells to ABT-737 and ABT-263 due to albumin binding in blood.

Vogler M, Furdas SD, Jung M, Kuwana T, Dyer MJ, Cohen GM.

Clin Cancer Res. 2010 Aug 15;16(16):4217-25. doi: 10.1158/1078-0432.CCR-10-0777. Epub 2010 Jul 2.

44.

The Hsp90 co-chaperone p23 of Toxoplasma gondii: Identification, functional analysis and dynamic interactome determination.

Echeverria PC, Figueras MJ, Vogler M, Kriehuber T, de Miguel N, Deng B, Dalmasso MC, Matthews DE, Matrajt M, Haslbeck M, Buchner J, Angel SO.

Mol Biochem Parasitol. 2010 Aug;172(2):129-40. doi: 10.1016/j.molbiopara.2010.04.004. Epub 2010 Apr 18.

45.

Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells.

Baou M, Kohlhaas SL, Butterworth M, Vogler M, Dinsdale D, Walewska R, Majid A, Eldering E, Dyer MJ, Cohen GM.

Haematologica. 2010 Sep;95(9):1510-8. doi: 10.3324/haematol.2010.022368. Epub 2010 Apr 7.

46.

The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia.

Lubenow N, Hinz P, Thomaschewski S, Lietz T, Vogler M, Ladwig A, Jünger M, Nauck M, Schellong S, Wander K, Engel G, Ekkernkamp A, Greinacher A.

Blood. 2010 Mar 4;115(9):1797-803. doi: 10.1182/blood-2009-07-231506. Epub 2009 Nov 20.

47.

Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment.

Volberding P, Demeter L, Bosch RJ, Aga E, Pettinelli C, Hirsch M, Vogler M, Martinez A, Little S, Connick E; ACTG 371 Team.

AIDS. 2009 Sep 24;23(15):1987-95. doi: 10.1097/QAD.0b013e32832eb285.

48.

Acute MI with long-standing AIDS: a perfect storm of risk factors for premature coronary artery disease.

Vogler MA.

AIDS Read. 2009 May;19(5):196-200. No abstract available.

PMID:
19554739
49.

Different forms of cell death induced by putative BCL2 inhibitors.

Vogler M, Weber K, Dinsdale D, Schmitz I, Schulze-Osthoff K, Dyer MJ, Cohen GM.

Cell Death Differ. 2009 Jul;16(7):1030-9. doi: 10.1038/cdd.2009.48. Epub 2009 Apr 24.

50.

Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.

Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Bhanot U, Hasel C, Möller P, Gschwend JE, Simmet T, Debatin KM, Fulda S.

Cancer Res. 2009 Mar 15;69(6):2425-34. doi: 10.1158/0008-5472.CAN-08-2436. Epub 2009 Mar 3.

Supplemental Content

Loading ...
Support Center